Hemophilia A and B mice, but not VWF


Journal

Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288

Informations de publication

Date de publication:
08 10 2019
Historique:
received: 30 10 2018
accepted: 19 09 2019
entrez: 10 10 2019
pubmed: 9 10 2019
medline: 3 11 2020
Statut: epublish

Résumé

While joint damage is the primary co-morbidity of hemophilia, osteoporosis and osteopenia are also observed. Coagulation factor VIII deficient (FVIII

Identifiants

pubmed: 31594977
doi: 10.1038/s41598-019-50787-9
pii: 10.1038/s41598-019-50787-9
pmc: PMC6783554
doi:

Substances chimiques

Interleukin-6 0
RANK Ligand 0
Sp7 Transcription Factor 0
Sp7 protein, mouse 0
Tnfsf11 protein, mouse 0
von Willebrand Factor 0
Factor VIII 9001-27-8
Factor IX 9001-28-9

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

14428

Références

Haemophilia. 2013 Jan;19(1):e1-47
pubmed: 22776238
Blood. 1997 Nov 15;90(10):3962-6
pubmed: 9354664
Haemophilia. 2009 Mar;15(2):559-65
pubmed: 19187193
Transfus Apher Sci. 2008 Feb;38(1):33-40
pubmed: 18255340
Br J Haematol. 2012 Jul;158(1):140-3
pubmed: 22469061
Blood. 2015 Mar 26;125(13):2160-3
pubmed: 25645354
Rheumatol Int. 2008 Sep;28(11):1079-83
pubmed: 18500466
J Bone Miner Res. 1994 Aug;9(8):1137-41
pubmed: 7976495
Hum Gene Ther. 2015 Feb;26(2):69-81
pubmed: 25419787
J Cell Physiol. 2005 Aug;204(2):714-23
pubmed: 15799029
Cytokine. 2000 Oct;12(10):1455-68
pubmed: 11023660
Haemophilia. 2006 Nov;12(6):672-5
pubmed: 17083520
J Thromb Haemost. 2007 Sep;5(9):1956-62
pubmed: 17723135
Haemophilia. 2009 Jul;15(4):918-25
pubmed: 19473418
Haemophilia. 2015 Sep;21(5):568-77
pubmed: 26172840
Haemophilia. 2017 Jul;23(4):511-520
pubmed: 28370924
Blood. 2017 Apr 13;129(15):2161-2171
pubmed: 28039188
J Thromb Haemost. 2013 May;11(5):881-93
pubmed: 23413986
Nat Genet. 1995 May;10(1):119-21
pubmed: 7647782
Haemophilia. 2009 Jan;15(1):261-6
pubmed: 19149852
Cytokine Growth Factor Rev. 2004 Feb;15(1):49-60
pubmed: 14746813
Haemophilia. 2013 Nov;19(6):908-12
pubmed: 23731369
Q J Med. 1994 Mar;87(3):181-6
pubmed: 8208906
Br J Haematol. 1995 Jan;89(1):147-51
pubmed: 7833254
Br J Haematol. 2011 May;153(3):364-71
pubmed: 21391975
Osteoporos Int. 2014 Oct;25(10):2399-407
pubmed: 25001982
Bone. 2003 Oct;33(4):733-43
pubmed: 14555279
Cell Mol Life Sci. 2007 Sep;64(18):2334-50
pubmed: 17530461
J Biol Chem. 2009 Nov 13;284(46):31704-13
pubmed: 19758994
Haemophilia. 2014 Sep;20(5):716-22
pubmed: 24712867
Haemophilia. 2006 Nov;12(6):654-62
pubmed: 17083517
Thromb Haemost. 2010 Mar;103(3):596-603
pubmed: 20076854
J Hepatol. 2005 Dec;43(6):973-83
pubmed: 16143421
Blood. 2008 Dec 1;112(12):4532-41
pubmed: 18716130
Int J Rheum Dis. 2009 Jul;12(2):125-9
pubmed: 20374329
Blood. 2013 Oct 10;122(15):2562-71
pubmed: 23982175
Semin Hematol. 2006 Jan;43(1 Suppl 1):S18-22
pubmed: 16427379
J Clin Invest. 2004 Feb;113(3):379-89
pubmed: 14755335
Pediatrics. 2004 Aug;114(2):e177-81
pubmed: 15286254
J Bone Miner Metab. 2014 Jul;32(4):378-92
pubmed: 24122251
Am J Pathol. 2015 Mar;185(3):765-75
pubmed: 25559270
J Clin Invest. 1977 Aug;60(2):390-404
pubmed: 17621
Trends Mol Med. 2009 Sep;15(9):417-29
pubmed: 19740701
Proc Natl Acad Sci U S A. 1998 Aug 4;95(16):9524-9
pubmed: 9689113
Bone. 2009 May;44(5):813-21
pubmed: 19442625
Bone. 2015 Apr;73:51-9
pubmed: 25532478
Horm Metab Res. 2006 Jun;38(6):417-22
pubmed: 16823725
J Bone Miner Res. 1996 Jan;11(1):88-95
pubmed: 8770701
Nature. 1979 Jun 14;279(5714):636-8
pubmed: 313016
Int J Biochem Cell Biol. 1997 Jan;29(1):91-105
pubmed: 9076944
Br J Haematol. 2000 Dec;111(4):1236-9
pubmed: 11167767
Haemophilia. 2007 May;13(3):340-3
pubmed: 17498088

Auteurs

Sarah Taves (S)

Department of Biomedical Engineering, University of North Carolina, Chapel Hill, NC, USA.
Global Research, Novo Nordisk A/S, Maløv, Denmark.

Junjiang Sun (J)

Gene Therapy Center, University of North Carolina, Chapel Hill, NC, USA.
Division of Molecular Pharmaceutics, Eshelman School of Pharmacy, University of North Carolina, Chapel Hill, NC, USA.

Eric W Livingston (EW)

Department of Biomedical Engineering, University of North Carolina, Chapel Hill, NC, USA.

Xin Chen (X)

Gene Therapy Center, University of North Carolina, Chapel Hill, NC, USA.

Jerome Amiaud (J)

INSERM, U1238, Faculty of Medicine, Université de Nantes, Nantes, F-44093, France.

Regis Brion (R)

INSERM, U1238, Faculty of Medicine, Université de Nantes, Nantes, F-44093, France.

William B Hannah (WB)

Gene Therapy Center, University of North Carolina, Chapel Hill, NC, USA.

Ted A Bateman (TA)

Department of Biomedical Engineering, University of North Carolina, Chapel Hill, NC, USA.
Department of Radiation Oncology, University of North Carolina, Chapel Hill, NC, USA.

Dominique Heymann (D)

INSERM, U1232, CRCiNA, Institut de Cancérologie de l'Ouest, Université de Nantes, Université d'Angers, Saint-Herblain, F-44805, France. dominique.heymann@univ-nantes.fr.
University of Sheffield, INSERM, Associated European Laboratory Sarcoma Research Unit, Department of Oncology and Metabolism, Sheffield, S10 2RX, UK. dominique.heymann@univ-nantes.fr.

Paul E Monahan (PE)

Gene Therapy Center, University of North Carolina, Chapel Hill, NC, USA. pablomonoloco@gmail.com.
Harold R. Roberts Comprehensive Hemophilia Diagnosis and Treatment Center, University of North Carolina, Chapel Hill, NC, USA. pablomonoloco@gmail.com.
Spark Therapeutics, Philadelphia, PA, USA. pablomonoloco@gmail.com.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH